Synaptogenix Inc (SNPX)

[SF Wolf]

Theburg, I answered your question a week or so ago concerning Option trading for NTRP:

As I have pointed out given the low float and high “borrow” cost at this juncture it is difficult and expensive to find stock to short. I know for a fact that Goldman Sachs and other top Wall Street firms are shorting or are facilitating customers who what to short the stock. When I inquired at Schwab that was what I was told. One problem is they just can’t short with any volume to knock the share price down.

Looking ahead, once NTRP is on NASDAQ, will options become available? Options can be used to hedge a short position affording some protection if the share price was to move to the upside. Option trading does not happen automatically when a stock is listed on NASDAQ.

According to Investopedia companies must meet four criteria before options on their stock can be traded on options exchanges:

1. The underlying equity security must be listed on the NYSE, AMEX or Nasdaq.
2. The closing price must have a minimum per share price for a majority of trading days during the three prior calendar months.
3. The company must have at least 7,000,000 publicly held shares.
4. The company must have at least 2,000 shareholders.
If a company does not meet any one of these criteria, options exchanges such as the Chicago Board Options Exchange will not allow any options to be traded on the underlying security. Additionally, because of the second condition listed above, a company cannot have options traded on it until at least three months after its initial public offering date.
http://www.investopedia.com/ask/answers/04/072104.asp#ixzz4b3QkkIai


Looking at the above criteria numbers 3 and 4 probably will disqualify NTRP from being listed on the options market any time soon. Personally I view that as a favorable situation if you are long the stock. It means price discovery will be based on company news and developments and not on games played by a cabal of short sellers.